Harimurti Nuradji

Harimurti Nuradji

Auto-generated profile, based on publicly available information

Harimurti Nuradji

National Research and Innovation Agency

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
NDnlp Indi Dharmayanti
nlp Indi Dharmayanti
DNDiana Nurjanah
Diana Nurjanah
HNHarimurti Nuradji
Harimurti Nuradji
TSTeguh Suyatno
Teguh Suyatno
RIRisa Indriani
Risa Indriani
Dharmayanti NI, et al. J Vet Sci. 2023 Dec;25(1):e3. https://doi.org/10.4142/jvs.23022

20 January 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
STSimson Tarigan
Simson Tarigan
NDN L P Indi Dharmayanti
N L P Indi Dharmayanti
DSDianita Sugiartanti
Dianita Sugiartanti
RPRyandini Putri
Ryandini Putri
HNHarimurti Nuradji
Harimurti Nuradji
FDFadjry Djufri
Fadjry Djufri
The vital roles of diagnostic tools and vaccines are prominent in controlling COVID-19. Spike protein of the SARS CoV-2, specifically the epitopes in that protein, are the critical components of the vaccines and immunological diagnostic tools. Two epitopes in the spike protein, the S14P5 and S21P2, identified previously are of great interest because they are linear and elicit neutralizing antibodies. The present study formulated each epitope in the tandem-repeat structure to increase their immunogenicity and facilitate their production. The tandem repeats (TR) were expressed efficiently in E. coli, yielding 58 mg and 46 mg per liter culture for TR-S14P5 and TR-S212, respectively. ELISA using either one of the repeating epitopes can be used as a serological test to identify individuals infected by the SARS-CoV-2 virus. The area under curves (AUC), based on testing 157 serum samples from COVID-19 patients and 26 from COVID-19-free individuals, were 0.806 and 0.889 for TR-S14P5 and TR-S21P2-based ELISAs, respectively. For 100% diagnostic specificity, the sensitivity was only 70%. The low sensitivity supposedly resulted from some samples being from early infection prior to antibody conversion. Both recombinant epitopes were highly immunogenic in rabbits, and the immune sera recognized inactivated SARS CoV-2 virus in dot-blot assays. These antibodies should be useful as a reagent for detecting SARS-CoV-2 antigens. Furthermore, the TR-S14P5 and TR-S21P2, being conserved and denaturation-resistant, are envisaged to be ideal for intra-nasal vaccines, which are required to complement current COVID-19 to overcome rapidly mutated SARS CoV-2.

1 January 2021 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
NDnlp Indi Dharmayanti
nlp Indi Dharmayanti
DNDiana Nurjanah
Diana Nurjanah
HNHarimurti Nuradji
Harimurti Nuradji
IMIbnu Maryanto
Ibnu Maryanto
IEIndra Exploitasia
Indra Exploitasia
RIRisa Indriani
Risa Indriani
Dharmayanti NL, et al. J Vet Sci. 2021 Aug;22(6):e70. https://doi.org/10.4142/jvs.2021.22.e70

23 April 2025 in Veterinary World
Verified
Journal Article
Open access
NDnlp Indi Dharmayanti
nlp Indi Dharmayanti
DNDiana Nurjanah
Diana Nurjanah
RIRisa Indriani
Risa Indriani
TSTeguh Suyatno
Teguh Suyatno
HNHarimurti Nuradji
Harimurti Nuradji
Background and Aim: Despite the global focus on coronavirus disease 2019 (COVID-19), the avian influenza virus (AIV) continues to circulate in Indonesia, particularly in traditional live bird markets (LBMs), which serve as critical nodes for virus amplification and interspecies transmission. This study aimed to investigate the co-circulation and genetic features of AIV, particularly the H9N2 subtype, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in LBMs in East Java during the COVID-19 pandemic. Materials and Methods: Environmental surveillance was conducted in seven traditional markets across four districts in East Java Province in 2021. Surface swabs were collected from high-risk areas, including poultry display tables, knives, cutting boards, and napkins. Samples were tested using reverse transcriptase polymerase chain reaction for influenza A and SARS-CoV-2. Positive AIV samples were further subtyped, sequenced, and analyzed for genetic markers associated with virulence, reassortment, and mammalian adaptation. Results: Of 156 samples tested, 17 (10.9%) were positive for influenza A, with 3 (1.9%) confirmed as the H9 subtype. These H9-positive samples were collected from a knife, cutting board, and napkin in the same market location in Lamongan Regency. Phylogenetic and molecular analyses revealed that two isolates (LSJ/Env/83 and LSJ/Env/84) were H9N2 reassortants, harboring key molecular markers such as Q226L, T160A, and S138A in the hemagglutinin protein, indicative of increased affinity for human-type receptors. Additional substitutions in PB2, MP, and NS1 proteins were associated with enhanced replication and virulence in mammalian and avian hosts. All samples tested negative for SARS-CoV-2. Conclusion: This study demonstrates the continued environmental circulation of reassortant H9N2 AIVs in traditional markets during the COVID-19 pandemic, with isolates displaying genetic features indicative of zoonotic potential. These findings underscore the necessity for sustained genomic surveillance and stricter biosecurity interventions in LBMs to prevent cross-species transmission and mitigate pandemic risk. Keywords: coronavirus disease 2019, genomic surveillance, H9N2, influenza A virus, live bird markets, reassortment, zoonosis.

5 March 2024 in Veterinary World
Verified
Journal Article
Open access
ISIndrawati Sendow
Indrawati Sendow
HHHeri Hoerudin
Heri Hoerudin
RHRisza Hartawan
Risza Hartawan
NFNuha Fairusya
Nuha Fairusya
ARAtik Ratnawati
Atik Ratnawati
ECEmdadul Chowdhury
Emdadul Chowdhury
Therefore, the main objective of this study was to identify PPR seroprevalence in the buffalo population of Indonesia.

30 March 2025 in International Journal of One Health
Verified
Journal Article
Open access
AKAswin Rafif Khairullah
Aswin Rafif Khairullah
HNHarimurti Nuradji
Harimurti Nuradji
DNDiana Nurjanah
Diana Nurjanah
NDnlp Indi Dharmayanti
nlp Indi Dharmayanti
BWBantari Wisynu Wisynu Kusuma Kusuma Wardhani
Bantari Wisynu Wisynu Kusuma Kusuma Wardhani
KFKartika Afrida Fauzia
Kartika Afrida Fauzia
Background and Aim: Legionnaires’ disease (LD), caused by the Gram-negative bacterium Legionella pneumophila, has emerged as a significant public health concern due to its rising incidence and high morbidity and mortality rates. This review comprehensively examines the etiology, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and prevention of LD. The bacterium thrives in aquatic environments, often within biofilms and protozoan hosts, contributing to its resilience and widespread distribution in natural and man-made water systems. Transmission primarily occurs through the inhalation of contaminated aerosols, with immunocompromised individuals, the elderly, and smokers being at heightened risk. Clinically, LD presents as a severe pneumonia with systemic involvement, and its diagnosis often relies on culture, urinary antigen tests, and molecular methods. The treatment landscape is dominated by macrolides and fluoroquinolones, with emerging research into alternative therapies to combat antimicrobial resistance. Effective public health strategies, including rigorous water management practices and infection control measures, are vital in mitigating the risk of outbreaks. This review aims to enhance clinical awareness and inform public health initiatives by elucidating the complex interplay between bacterial virulence, host factors, and environmental conditions that contribute to LD transmission and persistence. A better understanding of these dynamics is crucial for developing robust prevention and control strategies, ultimately reducing the global burden of this potentially life-threatening disease. Keywords: Legionella pneumophila, Legionnaires’ disease, pneumonia, public health, waterborne pathogens.